Arcturus Therapeutics Holdings Overview
Arcturus Therapeutics Holdings Discounted Cash Flow
DCF Analysis for ARCT.
Get informed when a big investor buys or sells
+ FollowFair Value
$-6.02
Current Fair Value
$-6.02
↓ 182.2% Downside
Overvalued by 182.2% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison